Merck will buy UK-based Verona Pharma for about $10 billion, the companies said on Wednesday.
Related Posts
‘Everyone is calling’: Trump’s tariff threats send U.S. companies scrambling for lobbyists and loopholes
Donald Trump campaigned on hardline tariff proposals that alarmed economists, corporate America and Wall Street.
Asia-Pacific markets rise as investors parse a slew of data releases
Investors will be keeping a close watch on Chinese manufacturing and non-manufacturing PMIs expected later in the day.
CNBC’s Most Valuable Sports Empires 2025: Here’s how the top 20 empires in the world stack up
The world’s 20 most valuable sports ownership groups are worth a combined $225 billion, according to CNBC’s Most Valuable Sports Empires 2025.